Diagnosis and treatment of chronic prostatitis caused by Chlamydia trachomatis [3]

Journal of Chemotherapy

Volumn 17, Issue 5, 2005, Pages 570-571

  Škerk, Višnja ^a   Sternak, S Ljubin ^b   Roglic S ^a   Škerk, Vedrana ^c   Lisic M ^a  

^a Croatia   (Croatia)

^b CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ADULT; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHLAMYDIA TRACHOMATIS; CHRONIC PROSTATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DNA RNA HYBRIDIZATION; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; IMMUNOFLUORESCENCE; LETTER; MALE; PROSTATE SECRETION; SIDE EFFECT; URINALYSIS;

EID: 28144462260     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.5.570     Document Type: Letter

References (4)

1. Weidner W, Diemer Th, Huwe P, Rainer M, Ludwig M. The role of Chlamydia trachomatis in prostatitis. Int J Antimicrob Agents 2002; 19:466-70.
2. Škerk V, Krhen I, Schonwald S, et al. The role of unusual pathogen in prostatitis syndrome. Int J Antimicrob Agents, 2004; 245:53-56.
3. Škerk V, Schonwald S, Krhen I, et al. Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2001; 13:664-665.
4. Škerk V, Krhen I, Lisić M, et al. Azithromycin: 4.5 or 6.0 gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis - a randomized study. J Chemother 2004; 16:408-410.